Molecular design of allergy vaccines

Current Opinion in Immunology

Volumn 17, Issue 6, 2005, Pages 646-655

  Linhart, Birgit ^a   Valenta, Rudolf ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; AMB A 1 PEPTIDE OLIGONUCLEOTIDE CONJUGATE; API M 1 PEPTIDE; API M 2 PEPTIDE; ARA H 1 PEPTIDE; ARA H 2 PEPTIDE; ARA H 3 PEPTIDE; BACTERIAL ANTIGEN; BET V 1 PEPTIDE; BET V 1 PEPTIDE S LAYER PROTEIN CONJUGATE; DER P 2 PEPTIDE; DNA VACCINE; FEL D 1 PEPTIDE; FEL D 1 PEPTIDE IGG FC GAMMA CONJUGATE; GAL D 1 PEPTIDE; HEV B 6.01 PEPTIDE; HEV B 6.02 PEPTIDE; LOL P 5 PEPTIDE; PAR J 1 PEPTIDE; PAR J 2 PEPTIDE; PHL P 1 PEPTIDE; PHL P 2 PEPTIDE; PHL P 5 PEPTIDE; PHL P 6 PEPTIDE; PHL P 7 PEPTIDE; POL A 5 PEPTIDE; POLLEN ANTIGEN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINE; VES V 5 PEPTIDE;

ALLERGENICITY; ALLERGY; ANTIGEN STRUCTURE; AUTOIMMUNITY; CHEMICAL STRUCTURE; CLINICAL TRIAL; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFECTION; LISTERIA MONOCYTOGENES; NONHUMAN; POLLEN ALLERGY; REVIEW; SENSITIZATION; TUMOR IMMUNITY; VACCINATION;

ALLERGENS; CLINICAL TRIALS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; VACCINES;

EID: 27144547578     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.09.010     Document Type: Review

References (124)

1. H. von Boehmer, and M.C. Nussenzweig The manipulation of immunity. Conference on "From allergy to cancer: new perspectives for therapeutic vaccination" EMBO Rep 5 2004 765 770 A timely review of immune intervention strategies.
2. R. Valenta The future of antigen-specific immunotherapy of allergy Nat Rev Immunol 2 2002 446 453
3. R. Valenta, T. Ball, M. Focke, B. Linhart, N. Mothes, V. Niederberger, S. Spitzauer, I. Swoboda, S. Vrtala, and K. Westritschnig Immunotherapy of allergic disease Adv Immunol 82 2004 105 153 A comprehensive review of the immunotherapy of allergy.
4. Valenta R, Kraft D (Eds): Recombinant allergens: from production and characterization to diagnosis, treatment, and prevention of allergy. Methods 2004, 32.
5. P. Neudecker, K. Lehmann, J. Nerkamp, T. Haase, A. Wangorsch, K. Fotisch, S. Hoffmann, P. Rosch, S. Vieths, and S. Scheurer Mutational epitope analysis of Pru av 1 and Api g 1, the major allergens of cherry (Prunus avium) and celery (Apium graveolens): correlating IgE reactivity with three-dimensional structure Biochem J 376 2003 97 107
6. M.D. Spangfort, O. Mirza, H. Ipsen, R.J. Van Neerven, M. Gajhede, and J.N. Larsen Dominating IgE-binding epitope of Bet v 1, the major allergen of birch pollen, characterized by X-ray crystallography and site-directed mutagenesis J Immunol 171 2003 3084 3090
7. T. Ball, W. Edstrom, L. Mauch, J. Schmitt, B. Leistler, H. Fiebig, W.R. Sperr, A.W. Hauswirth, P. Valent, and D. Kraft Gain of structure and IgE epitopes by eukaryotic expression of the major Timothy grass pollen allergen, Phl p 1 FEBS J 272 2005 217 227
8. Fedorov AA, Ball T, Leistler B, Valenta R, Almo SC: Crystal structure of Phl p 1, a major Timothy grass pollen allergen. PDB: 1N10.
9. Fedorov AA, Ball T, Fedorov EV, Vrtala S, Valenta R, Almo SC: Crystal structure of Phl p 6, a major Timothy grass pollen allergen co-crystallized with zinc. PDB: 1NLX.
10. E.W. Czerwinski, T. Midoro-Horiuti, M.A. White, E.G. Brooks, and R.M. Goldblum Crystal structure of Jun a 1, the major cedar pollen allergen from Juniperus ashei, reveals a parallel beta-helical core J Biol Chem 280 2005 3740 3746
11. A. Gustchina, M. Li, S. Wunschmann, M.D. Chapman, A. Pomes, and A. Wlodawer Crystal structure of cockroach allergen Bla g 2, an unusual zinc binding aspartic protease with a novel mode of self-inhibition J Mol Biol 348 2005 433 444
12. J. Reisinger, A. Triendl, E. Kuchler, B. Bohle, M.T. Krauth, I. Rauter, P. Valent, F. Koenig, R. Valenta, and V. Niederberger IFN-gamma-enhanced allergen penetration across respiratory epithelium augments allergic inflammation J Allergy Clin Immunol 115 2005 973 981
13. L. Johansson, L. Svensson, U. Bergstrom, G. Jacobsson-Ekman, E.S. Arner, M. van Hage, A. Bucht, and G. Gafvelin A mouse model for in vivo tracking of the major dust mite allergen Der p 2 after inhalation FEBS J 272 2005 3449 3460
14. M. Akdis, J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, R. Crameri, S. Thunberg, G. Deniz, R. Valenta, and H. Fiebig Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells J Exp Med 199 2004 1567 1575 A description of allergen-specific regulatory cells.
15. B. Jahn-Schmid, A. Radakovics, D. Luttkopf, S. Scheurer, S. Vieths, C. Ebner, and B. Bohle Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens J Allergy Clin Immunol 116 2005 213 219
16. A.J. Reefer, R.M. Carneiro, N.J. Custis, T.A. Platts-Mills, S.S. Sung, J. Hammer, and J.A. Woodfolk A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen J Immunol 172 2004 2763 2772
17. B. Jahn-Schmid, G.F. Fischer, B. Bohle, I. Fae, G. Gadermaier, A. Dedic, F. Ferreira, and C. Ebner Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1*01 J Allergy Clin Immunol 115 2005 399 404
18. S. Scheurer, I. Lauer, K. Foetisch, M.S. Moncin, M. Retzek, C. Hartz, E. Enrique, J. Lidholm, A. Cistero-Bahima, and S. Vieths Strong allergenicity of Pru av 3, the lipid transfer protein from cherry, is related to high stability against thermal processing and digestion J Allergy Clin Immunol 114 2004 900 907
19. T. Takai, T. Kato, M. Ota, H. Yasueda, T. Kuhara, K. Okumura, and H. Ogawa Recombinant Der p 1 and Der f 1 with in vitro Enzymatic Activity to Cleave Human CD23, CD25 and alpha(1)-Antitrypsin, and in vivo IgE-Eliciting Activity in Mice Int Arch Allergy Immunol 137 2005 194 200
20. A. Purohit, S. Laffer, C. Metz-Favre, A. Verot, F. Kricek, R. Valenta, and G. Pauli Poor association between allergen-specific serum immunoglobulin E levels, skin sensitivity and basophil degranulation: a study with recombinant birch pollen allergen Bet v 1 and an immunoglobulin E detection system measuring immunoglobulin E capable of binding to Fc epsilon RI Clin Exp Allergy 35 2005 186 192
21. R. Buender, I. Mittermann, U. Herz, M. Focke, M. Wegmann, R. Valenta, and H. Renz Induction of autoallergy with an environmental allergen mimicking a self protein in a murine model of experimental allergic asthma J Allergy Clin Immunol 114 2004 422 428
22. P. Schmid-Grendelmeier, S. Fluckiger, R. Disch, A. Trautmann, B. Wuthrich, K. Blaser, A. Scheynius, and R. Crameri IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis J Allergy Clin Immunol 115 2005 1068 1075
23. K.J. Aichberger, I. Mittermann, R. Reininger, S. Seiberler, I. Swoboda, S. Spitzauer, T. Kopp, G. Stingl, W.R. Sperr, and P. Valent Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivity J Immunol 175 2005 1286 1294
24. W.R. Thomas, W.A. Smith, B.J. Hales, K.L. Mills, and R.M. O'Brien Characterization and immunobiology of house dust mite allergens Int Arch Allergy Immunol 129 2002 1 18
25. P. Colombo, A. Bonura, M. Costa, V. Izzo, R. Passantino, G. Locorotondo, S. Amoroso, and D. Geraci The allergens of Parietaria Int Arch Allergy Immunol 130 2003 173 179
26. K.H. Roux, S.S. Teuber, and S.K. Sathe Tree nut allergens Int Arch Allergy Immunol 131 2003 234 244
27. K. Andersson, and J. Lidholm Characteristics and immunobiology of grass pollen allergens Int Arch Allergy Immunol 130 2003 87 107
28. Z. Peng, and F.E. Simons Mosquito allergy: immune mechanisms and recombinant salivary allergens Int Arch Allergy Immunol 133 2004 198 209
29. N. Mothes, F. Horak, and R. Valenta Transition from a botanical to a molecular classification in tree pollen allergy: implications for diagnosis and therapy Int Arch Allergy Immunol 135 2004 357 373
30. Wopfner N, Gadermaier G, Egger M, Asero R, Ebner C, Jahn-Schmid B, Ferreira F: The spectrum of allergens in ragweed and mugwort pollen. Int Arch Allergy Immunol 2005, in press.
31. A. Mari The importance of data bases in experimental and clinical allergology Int Arch Allergy Immunol 138 2005 88 96
32. R. Hiller, S. Laffer, C. Harwanegg, M. Huber, W.M. Schmidt, A. Twardosz, B. Barletta, W.M. Becker, K. Blaser, and H. Breiteneder Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment FASEB J 16 2002 414 416
33. B.I. Fall, B. Eberlein-Konig, H. Behrendt, R. Niessner, J. Ring, and M.G. Weller Microarrays for the screening of allergen-specific IgE in human serum Anal Chem 75 2003 556 562
34. B. Jahn-Schmid, C. Harwanegg, R. Hiller, B. Bohle, C. Ebner, O. Scheiner, and M.W. Mueller Allergen microarray: comparison of microarray using recombinant allergens with conventional diagnostic methods to detect allergen-specific serum immunoglobulin E Clin Exp Allergy 33 2003 1443 1449
35. K. Deinhofer, H. Sevcik, N. Balic, C. Harwanegg, R. Hiller, H. Rumpold, M.W. Mueller, and S. Spitzauer Microarrayed allergens for IgE profiling Methods 32 2004 249 254
36. C. Harwanegg, S. Laffer, R. Hiller, M.W. Mueller, D. Kraft, S. Spitzauer, and R. Valenta Microarrayed recombinant allergens for diagnosis of allergy Clin Exp Allergy 33 2003 7 13
37. A. Mari Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: epidemiological and diagnostic data Clin Exp Allergy 33 2003 43 51
38. S.M. Satinover, A.J. Reefer, A. Pomes, M.D. Chapman, T.A. Platts-Mills, and J.A. Woodfolk Specific IgE and IgG antibody-binding patterns to recombinant cockroach allergens J Allergy Clin Immunol 115 2005 803 809
39. K. Westritschnig, E. Sibanda, W. Thomas, H. Auer, H. Aspock, G. Pittner, S. Vrtala, S. Spitzauer, D. Kraft, and R. Valenta Analysis of the sensitization profile towards allergens in central Africa Clin Exp Allergy 33 2003 22 27
40. N. Ghunaim, H. Gronlund, M. Kronqvist, R. Gronneberg, L. Soderstrom, S. Ahlstedt, and M. van Hage-Hamsten Antibody profiles and self-reported symptoms to pollen-related food allergens in grass pollen-allergic patients from northern Europe Allergy 60 2005 185 191
41. R. Moverare, T. Petays, E. Vartiainen, and T. Haahtela IgE reactivity pattern to timothy and birch pollen allergens in Finnish and Russian Karelia Int Arch Allergy Immunol 136 2005 33 38
42. S. Stumvoll, K. Westritschnig, J. Lidholm, S. Spitzauer, P. Colombo, G. Duro, D. Kraft, D. Geraci, and R. Valenta Identification of cross-reactive and genuine Parietaria judaica pollen allergens J Allergy Clin Immunol 111 2003 974 979
43. I. Swoboda, A. Bugajska-Schretter, P. Verdino, W. Keller, W.R. Sperr, P. Valent, R. Valenta, and S. Spitzauer Recombinant carp parvalbumin, the major cross-reactive fish allergen: a tool for diagnosis and therapy of fish allergy J Immunol 168 2002 4576 4584
44. I. Swoboda, M. Grote, P. Verdino, W. Keller, M.B. Singh, N. De Weerd, W.R. Sperr, P. Valent, N. Balic, and R. Reichelt Molecular characterization of polygalacturonases as grass pollen-specific marker allergens: expulsion from pollen via submicronic respirable particles J Immunol 172 2004 6490 6500
45. R. Reininger, I. Swoboda, B. Bohle, A.W. Hauswirth, P. Valent, H. Rumpold, R. Valenta, and S. Spitzauer Characterization of recombinant cat albumin Clin Exp Allergy 33 2003 1695 1702
46. G. Pittner, S. Vrtala, W.R. Thomas, M. Weghofer, M. Kundi, F. Horak, D. Kraft, and R. Valenta Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens Clin Exp Allergy 34 2004 597 603
47. A.P. Knutsen, P.S. Hutcheson, R.G. Slavin, and V.P. Kurup IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis Allergy 59 2004 198 203
48. R. Barderas, A. Purohit, I. Papanikolaou, R. Rodriguez, G. Pauli, and M. Villalba Cloning, expression, and clinical significance of the major allergen from ash pollen, Fra e 1 J Allergy Clin Immunol 115 2005 351 357
49. I. Lauer, K. Foetisch, D. Kolarich, B.K. Ballmer-Weber, A. Conti, F. Altmann, S. Vieths, and S. Scheurer Hazelnut (Corylus avellana) vicilin Cor a 11: molecular characterization of a glycoprotein and its allergenic activity Biochem J 383 2004 327 334
50. A.M. DeWitt, L. Mattsson, I. Lauer, G. Reese, and J. Lidholm Recombinant tropomyosin from Penaeus aztecus (rPen a 1) for measurement of specific immunoglobulin E antibodies relevant in food allergy to crustaceans and other invertebrates Mol Nutr Food Res 48 2004 370 379
51. F. Schocker, D. Luttkopf, S. Scheurer, A. Petersen, A. Cistero-Bahima, E. Enrique, M. San Miguel-Moncin, J. Akkerdaas, R. van Ree, and S. Vieths Recombinant lipid transfer protein Cor a 8 from hazelnut: a new tool for in vitro diagnosis of potentially severe hazelnut allergy J Allergy Clin Immunol 113 2004 141 147
52. L. Zuidmeer, W.A. van Leeuwen, I. Kleine Budde, J. Cornelissen, I. Bulder, I. Rafalska, N. Tellez Besoli, J.H. Akkerdaas, R. Asero, and M. Fernandez Rivas Lipid Transfer Proteins from Fruit: Cloning, Expression and Quantification Int Arch Allergy Immunol 137 2005 273 281
53. C. Hilger, J.C. Bessot, N. Hutt, F. Grigioni, F. De Blay, G. Pauli, and F. Hentges IgE-mediated anaphylaxis caused by bites of the pigeon tick Argas reflexus: cloning and expression of the major allergen Arg r 1 J Allergy Clin Immunol 115 2005 617 622
54. D.R. Hoffman, R.H. Sakell, and M. Schmidt Sol i 1, the phospholipase allergen of imported fire ant venom J Allergy Clin Immunol 115 2005 611 616
55. J.A. Asturias, I. Ibarrola, A. Ferrer, C. Andreu, E. Lopez-Pascual, J. Quiralte, F. Florido, and A. Martinez Diagnosis of Alternaria alternata sensitization with natural and recombinant Alt a 1 allergens J Allergy Clin Immunol 115 2005 1210 1217
56. S. Saarelainen, A. Taivainen, M. Rytkonen-Nissinen, S. Auriola, A. Immonen, R. Mantyjarvi, J. Rautiainen, T. Kinnunen, and T. Virtanen Assessment of recombinant dog allergens Can f 1 and Can f 2 for the diagnosis of dog allergy Clin Exp Allergy 34 2004 1576 1582
57. H. Gronlund, T. Bergman, K. Sandstrom, G. Alvelius, R. Reininger, P. Verdino, A. Hauswirth, K. Liderot, P. Valent, and S. Spitzauer Formation of disulfide bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli J Biol Chem 278 2003 40144 40151
58. U. Seppala, P. Hagglund, P.A. Wurtzen, H. Ipsen, P. Thorsted, T. Lenhard, P. Roepstorff, and M.D. Spangfort Molecular characterization of major cat allergen Fel d 1: expression of heterodimer by use of a baculovirus expression system J Biol Chem 280 2005 3208 3216
59. W. Smith, A.J. Butler, L.A. Hazell, M.D. Chapman, A. Pomes, D.G. Nickels, and W.R. Thomas Fel d 4, a cat lipocalin allergen Clin Exp Allergy 34 2004 1732 1738
60. N. Mothes, M. Heinzkill, K.J. Drachenberg, W.R. Sperr, M.T. Krauth, Y. Majlesi, H. Semper, P. Valent, V. Niederberger, and D. Kraft Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies Clin Exp Allergy 33 2003 1198 1208
61. P.A. Wachholz, N.K. Soni, S.J. Till, and S.R. Durham Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy J Allergy Clin Immunol 112 2003 915 922
62. R.J. van Neerven, M. Arvidsson, H. Ipsen, S.H. Sparholt, S. Rak, and P.A. Wurtzen A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation Clin Exp Allergy 34 2004 420 428
63. K.T. Nouri-Aria, P.A. Wachholz, J.N. Francis, M.R. Jacobson, S.M. Walker, L.K. Wilcock, S.Q. Staple, R.C. Aalberse, S.J. Till, and S.R. Durham Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity J Immunol 172 2004 3252 3259
64. R.E. Rossi, and G. Monasterolo Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients Int Arch Allergy Immunol 135 2004 44 53
65. S.T. Bolhaar, M.M. Tiemessen, L. Zuidmeer, A. van Leeuwen, K. Hoffmann-Sommergruber, C.A. Bruijnzeel-Koomen, L.S. Taams, E.F. Knol, E. van Hoffen, and R. van Ree Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges Clin Exp Allergy 34 2004 761 769
66. V. Niederberger, F. Horak, S. Vrtala, S. Spitzauer, M.T. Krauth, P. Valent, J. Reisinger, M. Pelzmann, B. Hayek, and M. Kronquist Vaccination with genetically engineered allergens prevents progression of allergic disease Proc Natl Acad Sci USA 101 2004 14677 14682 The first immunotherapy trial with genetically modified allergens.
67. J. Reisinger, F. Horak, G. Pauli, M. van Hage, O. Cromwell, F. König, R. Valenta, and V. Niederberger Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sentitivity J Allergy Clin Immunol 116 2005 347 354 Demonstration that allergen-specific IgG induced by vaccination with genetically-modified allergens protects against nasal allergen challenge.
68. S. Flicker, and R. Valenta Renaissance of the blocking antibody concept in Typ I allergy Int Arch Allergy Immunol 132 2003 13 24
69. B. Linhart, and R. Valenta Vaccine engineering improved by hybrid technology Int Arch Allergy Immunol 134 2004 324 331
70. B.M. Haselden, A.B. Kay, and M. Larche Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions J Exp Med 189 1999 1885 1894
71. M. Focke, V. Mahler, T. Ball, W.R. Sperr, Y. Majlesi, P. Valent, D. Kraft, and R. Valenta Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination FASEB J 15 2001 2042 2044
72. M. Focke, B. Linhart, A. Hartl, U. Wiedermann, W.R. Sperr, P. Valent, J. Thalhamer, D. Kraft, and R. Valenta Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination Clin Exp Allergy 34 2004 1525 1533
73. K. Westritschnig, M. Focke, P. Verdino, W. Goessler, W. Keller, A. Twardosz, A. Mari, F. Horak, U. Wiedermann, and A. Hartl Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7 J Immunol 172 2004 5684 5692
74. B. Hantusch, S. Krieger, E. Untersmayr, I. Scholl, R. Knittelfelder, S. Flicker, S. Spitzauer, R. Valenta, G. Boltz-Nitulescu, O. Scheiner, and E. Jensen-Jarolim Mapping of conformational IgE epitopes on Phl p 5a by using mimotopes from a phage display library J Allergy Clin Immunol 114 2004 1294 1300
75. M. Draghi, E.R. Jarman, R. Grifantini, L. Galli-Stampino, J.R. Lamb, N.M. Valiante, and G. Grandi Different profile of CD8+ effector T cells induced in Der p 1-allergic and naive mice by DNA vaccination Eur J Immunol 32 2002 3720 3728
76. A. Jacquet, M. Magi, M. Haumont, M. Jurado, L. Garcia, and A. Bollen Absence of immunoglobulin E synthesis and airway eosinophilia by vaccination with plasmid DNA encoding ProDer p 1 Clin Exp Allergy 33 2003 218 225
77. A. Hartl, R. Hochreiter, T. Stepanoska, F. Ferreira, and J. Thalhamer Characterization of the protective and therapeutic efficiency of a DNA vaccine encoding the major birch pollen allergen Bet v 1a Allergy 59 2004 65 73
78. R. Hochreiter, T. Stepanoska, F. Ferreira, R. Valenta, S. Vrtala, J. Thalhamer, and A. Hartl Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen Eur J Immunol 33 2003 1667 1676
79. Y. Darcan, A. Petersen, W.M. Becker, J. Galle, M. Ernst, J. Ahmed, and U. Seitzer Immunoprophylaxis with DNA vaccination inhibits Th2-mediated responses and airway inflammation in mice sensitised with the major timothy grass pollen allergen Phl p 5b Vaccine 2005
80. Weiss R, Gabler M, Leitner WW, Kern K, Hauser-Kronberger C, Alinger B, Valenta R, Thalhamer J, Scheiblhofer S: Genetic vaccination with a low-dose replicon-based vaccine encoding the grass pollen allergen Phl p 5 protects from IgE production and pathological alterations in the lung. Allergy Clin Immunol Int 2005 Suppl. No.1 47.
81. Stepanoska T, Thalhamer T, Proell M, Ferreira F, Thalhamer J, Hartl A: A DNA-based multivaccine against 17kD cross reacting allergens protects against IgE induction in a mouse model of allergy. Allergy Clin Immunol Int 2005, Suppl. No.1:497.
82. S. Vrtala, K. Hirtenlehner, M. Susani, M. Akdis, F. Kussebi, C.A. Akdis, K. Blaser, P. Hufnagl, B.R. Binder, and A. Politou Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1 FASEB J 15 2001 2045 2047
83. V. Mahler, S. Vrtala, O. Kuss, T.L. Diepgen, R. Suck, O. Cromwell, H. Fiebig, A. Hartl, J. Thalhamer, and G. Schuler Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1 Clin Exp Allergy 34 2004 115 122
84. S. Vrtala, K. Hirtenlehner, L. Vangelista, A. Pastore, H.G. Eichler, W.R. Sperr, P. Valent, C. Ebner, D. Kraft, and R. Valenta Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy J Clin Invest 99 1997 1673 1681
85. J. Holm, M. Gajhede, M. Ferreras, A. Henriksen, H. Ipsen, J.N. Larsen, L. Lund, H. Jacobi, A. Millner, and P.A. Wurtzen Allergy vaccine engineering: epitope modulation of recombinant Bet v 1 reduces IgE binding but retains protein folding pattern for induction of protective blocking-antibody responses J Immunol 173 2004 5258 5267
86. A. Orlandi, F. Grasso, S. Corinti, M. Marinaro, A. Bonura, M. Boirivant, P. Colombo, and G. Di Felice The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization Clin Exp Allergy 34 2004 470 477
87. P. Karisola, J. Mikkola, N. Kalkkinen, K.J. Airenne, O.H. Laitinen, S. Repo, O.T. Pentikainen, T. Reunala, K. Turjanmaa, and M.S. Johnson Construction of hevein (Hev b 6.02) with reduced allergenicity for immunotherapy of latex allergy by comutation of six amino acid residues on the conformational IgE epitopes J Immunol 172 2004 2621 2628
88. A.C. Drew, N.P. Eusebius, L. Kenins, H.D. de Silva, C. Suphioglu, J.M. Rolland, and R.E. O'Hehir Hypoallergenic variants of the major latex allergen Hev b 6.01 retaining human T lymphocyte reactivity J Immunol 173 2004 5872 5879
89. I. Swoboda, N. De Weerd, P.L. Bhalla, V. Niederberger, W.R. Sperr, P. Valent, H. Kahlert, H. Fiebig, P. Verdino, and W. Keller Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy Eur J Immunol 32 2002 270 280
90. N. de Weerd, P.L. Bhalla, and M.B. Singh Oral immunization with a recombinant major grass pollen allergen induces blocking antibodies in mice Int Arch Allergy Immunol 130 2003 119 124
91. X.M. Li, K. Srivastava, J.W. Huleatt, K. Bottomly, A.W. Burks, and H.A. Sampson Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model J Immunol 170 2003 3289 3295
92. C. Buhot, A. Chenal, A. Sanson, S. Pouvelle-Moratille, M.H. Gelb, A. Menez, D. Gillet, and B. Maillere Alteration of the tertiary structure of the major bee venom allergen Api m 1 by multiple mutations is concomitant with low IgE reactivity Protein Sci 13 2004 2970 2978
93. T. Saarne, L. Kaiser, H. Gronlund, O. Rasool, G. Gafvelin, and M. van Hage-Hamsten Rational design of hypoallergens applied to the major cat allergen Fel d 1 Clin Exp Allergy 35 2005 657 663
94. Y. Mine, E. Sasaki, and J.W. Zhang Reduction of antigenicity and allergenicity of genetically modified egg white allergen, ovomucoid third domain Biochem Biophys Res Commun 302 2003 133 137
95. T.P. King, S.Y. Jim, R.I. Monsalve, A. Kagey-Sobotka, L.M. Lichtenstein, and M.D. Spangfort Recombinant allergens with reduced allergenicity but retaining immunogenicity of the natural allergens: hybrids of yellow jacket and paper wasp venom allergen antigen 5s J Immunol 166 2001 6057 6065
96. B. Linhart, B. Jahn-Schmid, P. Verdino, W. Keller, C. Ebner, D. Kraft, and R. Valenta Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity FASEB J 16 2002 1301 1303
97. F. Kussebi, F. Karamloo, C. Rhyner, P. Schmid-Grendelmeier, M. Salagianni, C. Mannhart, M. Akdis, L. Soldatova, Z. Markovic-Housley, and B.R. Von Beust A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy J Allergy Clin Immunol 115 2005 323 329
98. B. Linhart, A. Hartl, B. Jahn-Schmid, P. Verdino, W. Keller, M.T. Krauth, P. Valent, F. Horak, U. Wiedermann, and J. Thalhamer A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination J Allergy Clin Immunol 115 2005 1010 1016 Construction of a single recombinant hybrid molecules which resembles the epitopes present in a complex allergen source.
99. Colombo P, Bonura A, Geraci D, Artale A, Melis M, Di Felice G, Corinti S, Amoroso S: A hybrid expressing genetically engineered major allergens of the Parietaria pollen as a tool for specific allergy vaccination. Allergy Clin Immunol Int 2005, Suppl. No.1:504.
100. H. Tighe, K. Takabayashi, D. Schwartz, G. Van Nest, S. Tuck, J.J. Eiden, A. Kagey-Sobotka, P.S. Creticos, L.M. Lichtenstein, and H.L. Spiegelberg Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity J Allergy Clin Immunol 106 2000 124 134
101. J.D. Marshall, S. Abtahi, J.J. Eiden, S. Tuck, R. Milley, F. Haycock, M.J. Reid, A. Kagey-Sobotka, P.S. Creticos, and L.M. Lichtenstein Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy J Allergy Clin Immunol 108 2001 191 197
102. B. Bohle, A. Breitwieser, B. Zwolfer, B. Jahn-Schmid, M. Sara, U.B. Sleytr, and C. Ebner A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity J Immunol 172 2004 6642 6648
103. D. Zhu, C.L. Kepley, K. Zhang, T. Terada, T. Yamada, and A. Saxon A chimeric human-cat fusion protein blocks cat-induced allergy Nat Med 11 2005 446 449
104. T.N. Andersson, G.J. Ekman, H. Gronlund, E. Buentke, T.L. Eriksson, A. Scheynius, M. Van Hage-Hamsten, and G. Gafvelin A novel adjuvant-allergen complex, CBP-rFel d 1, induces up-regulation of CD86 expression and enhances cytikine release by human dendritic cells in vitro Immunology 113 2004 253 259
105. Y.H. Liu, M.C. Kao, Y.L. Lai, and J.J. Tsai Efficacy of local nasal immunotherapy for Dp2-induced airway inflammation in mice: Using Dp2 peptide and fungal immunomodulatory peptide J Allergy Clin Immunol 112 2003 301 310
106. G. Hall, C.G. Houghton, J.U. Rahbek, J.R. Lamb, and E.R. Jarman Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production Vaccine 21 2003 549 561
107. K. Hufnagl, B. Winkler, M. Focke, R. Valenta, O. Scheiner, H. Renz, and U. Wiedermann Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice J Allergy Clin Immunol 116 2005 370 376
108. M. Jutel, L. Jaeger, R. Suck, H. Meyer, H. Fiebig, and O. Cromwell Allergen specific immunotherapy with recombinant grass pollen allergens J Allergy Clin Immunol 116 2005 608 613 The authors report successful immunotherapy of grass pollen allergy with recombinant allergens.
109. G. Gafvelin, S. Thunberg, and M. Kronqvist Cytokine and antibody responses in birch pollen allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1 Int Arch Allergy Immunol 138 2005 59 66
110. Klimek L, Bachert C, Doemer C, Meyer H, Narkus A: Specific immunotherapy with recombinant birch pollen allergen rBet v 1-FV is clinically efficacious. Allergy Clin Immunol Int 2005, Suppl. No 1:15.
111. P.S. Norman, J.L. Ohman Jr., A.A. Long, P.S. Creticos, M.A. Gefter, Z. Shaked, R.A. Wood, P.A. Eggleston, K.B. Hafner, and P. Rao Treatment of cat allergy with T-cell reactive peptides Am J Respir Crit Care Med 154 1996 1623 1628
112. F.E. Simons, M. Imada, Y. Li, and W.T. Watson HayGlass KT: Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects Int Immunol 8 1996 1937 1945
113. J. Pene, A. Desroches, L. Paradis, B. Lebel, M. Farce, C.F. Nicodemus, H. Yssel, and J. Bousquet Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats J Allergy Clin Immunol 102 1998 571 578
114. P. Maguire, C. Nicodemus, D. Robinson, D. Aaronson, and D.T. Umetsu The safety and efficacy of ALLERVAX CAT in cat allergic patients Clin Immunol 93 1999 222 231
115. B.M. Haselden, M. Larche, Q. Meng, K. Shirley, R. Dworski, A.P. Kaplan, C. Bates, D.S. Robinson, S. Ying, and A.B. Kay Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid J Allergy Clin Immunol 108 2001 394 401
116. W.L. Oldfield, A.B. Kay, and M. Larche Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects J Immunol 167 2001 1734 1739
117. W.L. Oldfield, M. Larche, and A.B. Kay Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial Lancet 360 2002 47 53
118. F.R. Ali, W.L. Oldfield, N. Higashi, M. Larche, and A.B. Kay Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides Am J Respir Crit Care Med 169 2004 20 26
119. T.R. Smith, C. Alexander, A.B. Kay, M. Larche, and D.S. Robinson Cat allergen peptide immunotherapy reduces CD4(+) T cell responses to cat allergen but does not alter suppression by CD4(+) CD25(+) T cells: a double-blind placebo-controlled study Allergy 59 2004 1097 1101
120. A. Verhoef, C. Alexander, A.B. Kay, and M. Larche T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity PLoS Med 2 2005 e78 The authors report the induction of a regulatory T cell population by peptide immunotherapy.
121. C. Alexander, and S. Ying A BK, Larche M: Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects Clin Exp Allergy 35 2005 52 58
122. U. Muller, C.A. Akdis, M. Fricker, M. Akdis, T. Blesken, F. Bettens, and K. Blaser Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom J Allergy Clin Immunol 101 1998 747 754
123. J.M. Fellrath, A. Kettner, N. Dufour, C. Frigerio, D. Schneeberger, A. Leimgruber, G. Corradin, and F. Spertini Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial J Allergy Clin Immunol 111 2003 854 861
124. M.K. Tulic, P.O. Fiset, P. Christodoulopoulos, P. Vaillancourt, M. Desrosiers, F. Lavigne, J. Eiden, and Q. Hamid Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response J Allergy Clin Immunol 113 2004 235 241